Challenges and Strategies in Medication Management for Patients With Multiple Comorbidities
- PMID: 40662024
- PMCID: PMC12257869
- DOI: 10.7759/cureus.85992
Challenges and Strategies in Medication Management for Patients With Multiple Comorbidities
Abstract
As the global population ages, polypharmacy-the concurrent use of multiple medications-has become increasingly common among older adults with multiple chronic conditions. While often clinically necessary, polypharmacy is associated with significant challenges, including medication nonadherence, adverse drug events, and increased hospitalizations. This narrative review synthesizes current evidence to explore the burden of polypharmacy, identify barriers to safe medication use, and assess intervention strategies aimed at improving outcomes in older adults. Drawing from diverse sources including clinical trials, observational studies, and policy reports, this review highlights the multifaceted nature of medication management in older adults. Contributing factors to nonadherence include cognitive decline, regimen complexity, low health literacy, and fragmented care. Interventions such as pharmacist-led medication reviews, deprescribing initiatives, motivational interviewing, and digital health tools have demonstrated potential in improving adherence and therapeutic safety. Emerging approaches-including pharmacogenomic-guided prescribing and AI-driven clinical decision support-also offer promising avenues for personalized care. A comprehensive, multidisciplinary framework that incorporates patient-centered communication, integrated care models, and supportive policy infrastructure is essential for addressing the complexities of polypharmacy in older populations. Continued research and collaboration across healthcare disciplines will be critical to translating these strategies into routine practice and enhancing medication safety for this vulnerable demographic.
Keywords: artificial intelligence in healthcare; collaborative approach; deprescribing; digital health education; medication adherence; medication management; multimorbidity management; older adult; pharmacogenomics; polypharmacy.
Copyright © 2025, Adeyemi et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Interventions to improve the appropriate use of polypharmacy for older people.Cochrane Database Syst Rev. 2018 Sep 3;9(9):CD008165. doi: 10.1002/14651858.CD008165.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Oct 11;10:CD008165. doi: 10.1002/14651858.CD008165.pub5. PMID: 30175841 Free PMC article. Updated.
-
Interventions to improve the appropriate use of polypharmacy for older people.Cochrane Database Syst Rev. 2023 Oct 11;10(10):CD008165. doi: 10.1002/14651858.CD008165.pub5. Cochrane Database Syst Rev. 2023. PMID: 37818791 Free PMC article.
-
Effect of Medication Management at Home via Pharmacist-Led Home Televisits: Protocol for a Cluster Randomized Controlled Trial.JMIR Res Protoc. 2025 Feb 5;14:e65141. doi: 10.2196/65141. JMIR Res Protoc. 2025. PMID: 39908544 Free PMC article.
-
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.Cochrane Database Syst Rev. 2016 Mar 14;3(3):CD006560. doi: 10.1002/14651858.CD006560.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Jan 15;1:CD006560. doi: 10.1002/14651858.CD006560.pub4. PMID: 26976529 Free PMC article. Updated.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Decade of healthy ageing: baseline report. [ Jun; 2025 ]. 2021. https://www.who.int/publications/i/item/9789240017900 https://www.who.int/publications/i/item/9789240017900
-
- Organisation for Economic Co-operation and Development (OECD) (data drawn from Fig. Paris: OECD Publishing; [ Jun; 2025 ]. 2023. Health at a Glance 2023: OECD Indicators.
-
- An update on the clinical consequences of polypharmacy in older adults: a narrative review. Wastesson JW, Morin L, Tan EC, et al. Expert Opin Drug Saf. 2018;17:1185–1196. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials